Table 4.
Variables | MVPA minutes per excursion, RR (95% CI) | Active minutes per excursion, RR (95% CI) | Time spent away home (minutes) per excursion, RR (95% CI) | Steps per excursion, RR (95% CI) |
---|---|---|---|---|
5-unit (dB) decrement in IVF sensitivitya | 0.80 (0.65, 0.98)* | 0.81 (0.71, 0.92)* | 0.91 (0.80, 1.04) | 0.80 (0.72, 0.90)* |
VF damagea | ||||
Normal/Mild | Reference | Reference | Reference | Reference |
Moderate | 0.71 (0.50, 1.09) | 0.77 (0.60, 1.00)* | 0.99 (0.78, 1.25) | 0.81 (0.62, 1.05) |
Severe | 0.47 (0.23, 0.96)* | 0.48 (0.34, 0.67)* | 0.68 (0.48, 1.00) | 0.51 (0.35, 0.74)* |
Severity of VF damage on continuous and categorical scale were derived from different models, each containing the same covariates: age, race, sex, living arrangement, employment, education, comorbidity, polypharmacy, and cognitive function.
RR: Risk Ratio; MVPA: moderate & vigorous physical activity; VF: vision field; IVF: integrated vision field; dB: decibels; CI: confidence interval; Polypharmacy: ≥ 5 systemic prescription medications; Mini-Mental State Examination-Vision Impairment (maximum as 22).
p <0.05.